Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q9WN
|
|||
| Former ID |
DIB004911
|
|||
| Drug Name |
FC EPO
|
|||
| Synonyms |
Long acting erythropoietin (anemia), Merck Serono
Click to Show/Hide
|
|||
| Indication | Anemia [ICD-11: 3A00-3A9Z; ICD-9: 280-285] | Discontinued in Phase 1 | [1] | |
| Company |
Merck Serono SA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Erythropoietin (EPO) | Target Info | Agonist | [2] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| HIF-1 signaling pathway | ||||
| PI3K-Akt signaling pathway | ||||
| Jak-STAT signaling pathway | ||||
| Hematopoietic cell lineage | ||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | |||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | ||||
| EPO signaling pathway | ||||
| HIF-1-alpha transcription factor network | ||||
| Reactome | Regulation of gene expression by Hypoxia-inducible Factor | |||
| WikiPathways | EPO Receptor Signaling | |||
| Hematopoietic Stem Cell Differentiation | ||||
| Differentiation Pathway | ||||
| Regulation of Hypoxia-inducible Factor (HIF) by Oxygen | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027346) | |||
| REF 2 | Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing. Drug Test Anal. 2012 Nov;4(11):818-29. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.